Cargando…

Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence

Immuno-oncology is a rapidly evolving field with growing relevance in the treatment of numerous malignancies. The prior study of immunotherapy in dermatologic oncology has largely focused on cutaneous melanoma. However, recent focus has shifted to the use of immunotherapy to treat non-melanoma skin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stonesifer, Connor J., Djavid, A. Reza, Grimes, Joseph M., Khaleel, Alexandra E., Soliman, Yssra S., Maisel-Campbell, Amanda, Garcia-Saleem, Tiffany J., Geskin, Larisa J., Carvajal, Richard D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720968/ https://www.ncbi.nlm.nih.gov/pubmed/34988009 http://dx.doi.org/10.3389/fonc.2021.734354

Ejemplares similares

Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience
por: GARCIA-SALEEM, Tiffany J., et al.
Publicado: (2021)

Isolated cutaneous Pseudallescheria boydii abscess in an immunocompetent man
por: Stonesifer, Connor J., et al.
Publicado: (2022)

Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence
por: Djavid, Amir Reza, et al.
Publicado: (2021)

28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19
por: Garcia-Saleem, Tiffany J., et al.
Publicado: (2021)

Stenotrophomonas maltophilia–associated primary cutaneous anaplastic large-cell lymphoma
por: Stonesifer, Connor J., et al.
Publicado: (2021)

International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19
por: Geskin, Larisa J, et al.
Publicado: (2021)

461 A review of cutaneous lymphoma outcomes during COVID-19 pandemic at Columbia University
por: Garcia-Saleem, T., et al.
Publicado: (2021)

The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis
por: Gaydosik, Alyxzandria M., et al.
Publicado: (2023)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018)

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
por: Ho, Joel, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Advanced Acral Melanoma: A Systematic Review
por: Zheng, Qingyue, et al.
Publicado: (2020)

Assessment of clinical interruptions during the COVID-19 pandemic on the diagnosis of melanoma: A 30-month retrospective review
por: Stonesifer, Connor J., et al.
Publicado: (2022)

International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study
por: Geskin, Larisa J., et al.
Publicado: (2023)

Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review
por: Jessurun, Charissa A. C., et al.
Publicado: (2017)

Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan
por: Wu, Chiao-En, et al.
Publicado: (2020)

Operative management of immune checkpoint colitis following in-transit melanoma: Case report
por: Childers, Betzaira G., et al.
Publicado: (2023)

Reticular skin eruption as the initial sign of coronavirus disease 2019 infection
por: Strom, Mark A., et al.
Publicado: (2020)

Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients
por: Trager, Megan H, et al.
Publicado: (2020)

Loss of ‘Epidermal Melanin Unit’ Integrity in Human Skin During Melanoma-Genesis
por: Casalou, Cristina, et al.
Publicado: (2022)

Racial and ethnic disparities in the perception of respect from physicians among skin cancer patients in the United States
por: Fahmy, Lauren M., et al.
Publicado: (2023)

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
por: Gabryś, H. S., et al.
Publicado: (2022)

An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma
por: Pan, Chaohu, et al.
Publicado: (2023)

Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin Cancers
por: Guida, Michele, et al.
Publicado: (2022)

Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid
por: Beck, Kristen M., et al.
Publicado: (2016)

Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis
por: Sun, Qian, et al.
Publicado: (2022)

Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders
por: Vagher, Jennie, et al.
Publicado: (2022)

Risk of Pneumonitis Associated With Immune Checkpoint Inhibitors in Melanoma: A Systematic Review and Network Meta-Analysis
por: Sun, You-Meng, et al.
Publicado: (2021)

Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
por: Byun, Hwa Kyung, et al.
Publicado: (2021)

Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma
por: Schmidt, Teresa, et al.
Publicado: (2021)

Efficacy and Safety of Immune Checkpoint Blockades in the Treatment of Ocular Melanoma: A Systematic Review and Meta-Analysis
por: Zhao, Lu, et al.
Publicado: (2021)

Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience
por: Geskin, Larisa J., et al.
Publicado: (2021)

Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
por: Cerro, Paulina A., et al.
Publicado: (2022)

Bioinformatic-based genetic characterizations of neural regulation in skin cutaneous melanoma
por: Wang, Fengdi, et al.
Publicado: (2023)

The reporting of uveal melanoma cases to the cancer registry in North Carolina
por: Gordon, Kathleen G., et al.
Publicado: (2022)

Skin of color representation in dermoscopy studies distinguishing benign from malignant skin lesions: A scoping review
por: Fahmy, Lauren M., et al.
Publicado: (2023)

Perspectives on the recommendations for skin cancer management during the COVID-19 pandemic
por: Geskin, Larisa J., et al.
Publicado: (2020)

Enhanced Antitumor Response to Immune Checkpoint Blockade Exerted by Cisplatin-Induced Mutagenesis in a Murine Melanoma Model
por: Gorgun, Falih M., et al.
Publicado: (2021)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021)

ROS-Mediated Necrosis by Glycolipid Biosurfactants on Lung, Breast, and Skin Melanoma Cells
por: Haque, Farazul, et al.
Publicado: (2021)

Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma
por: Dong, Xubin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8ik71v9kv58n0nsspfga7a6jf